jRCT2080221293未知3 期
An open-label, add-on, drug-drug interaction study to assess the effect of FYX-051 on the pharmacokinetics and safety of warfarin in Japanese healthy adult male
试验速览
- 阶段
- 3 期
- 入组人数
- 12
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Open-label, add-on study
入排标准
- 年龄范围
- 20age old over 至 39age old under（—）
- 性别
- Male
入选标准
- •Japanese healthy adult male
排除标准
- •Patients with any disease
- •Subjects with any history of diseases that might affect the assessment in the study
- •Subjects expressing the CYP2C9*3 genotype
结局指标
主要结局
-
Pharmacokinetics and Safety
次要结局
未报告次要终点
研究者
相似试验
未知
3 期
An open-label, add-on, drug-drug interaction study to assess the effect of FYX-051 on the pharmacokinetics and safety of warfarin in Japanese healthy adult maleHealthy adult maleJPRN-jRCT2080221293SANWA KAGAKU KENKYUSHO CO.,LTD.12
进行中（未招募）
1 期
Open-Label, Multiple-Dose, Drug Interaction Study to Assess the Effect of Famotidine with or without Tenofovir on the Pharmacokinetics of Atazanavir when given with Ritonavir in HIV-Infected Subjects. Revised Protocol 02 incorporating amendment 03 (Version 1.0, Date 09-Mar-2007) and amendment 04 (Version 1.0, Date 02-Jul-2007). And Pharmacogenetics Blood Sample Amendment 01 - Site Specific (Version 5.0, Date 14-Sep-2006).HIV infected SubjectsMedDRA version: 8.1Level: LLTClassification code 10020161Term: HIV infectionEUCTR2006-003163-31-GBBristol-Myers Squibb International Corporation36
已完成
不适用
A Phase I, open-label, drug-drug interaction study between multiple oral doses of GLPG1972 and a single dose of midazolam in healthy male subjects.NL-OMON44611Galapagos NV18
进行中（未招募）
1 期
A study in healthy volunteers to discover how the test medicine interacts with other approved medicines1. Non-alcoholic steatohepatitis (NASH)2. Antipsychotic-induced weight gain (AIWG)ISRCTN10379288Corcept Therapeutics (United States)30
已完成
不适用
An Open-Label Two-Way Drug-Drug Interaction Study to Assess the Effect of Tenofovir on the Pharmacokinetics of BMS-790052 and the Effect of BMS-790052 on the Pharmacokinetics of Tenofovir in Healthy Subjectsviral liver inflammation10047438Hepatitis CNL-OMON36725Bristol-Myers Squibb21